In April 2021, ASKA transitioned to a holding company structure, launching the ASKA Pharmaceutical Group.
Click the following link for the website of ASKA Pharmaceutical Holdings Co., Ltd.
NEWS RELEASES
- August 23 2024 Personnel Change of ASKA Pharmaceutical
- August 16 2024 ASKA Pharmaceutical licensee Hyundai Receives Manufacturing and Marketing Approval in Republic of Korea for Oral Contraceptive Drospirenone
- June 25 2024 Personnel Changes of Board Members and Corporate Officers of ASKA Pharmaceutical Holdings Subsidiaries
- June 24 2024 ASKA Pharmaceutical Files an Application for Manufacturing and Marketing Approval for LF111 in Japan
- May 31 2024 Licensing Agreement for Relugolix Combination Tablet for Endometriosis in the Gynecologic Disease Area
For the previous news releases, please refer to the website of ASKA Pharmaceutical Holdings Co., Ltd.
About ASKA
ASKA Pharmaceutical Group
